Kolarić K, Roth A, Dominis M, Jakasa V
Acta Hepatogastroenterol (Stuttg). 1977 Dec;24(6):440-3.
Since the presence of the pathological liver process definitely changes the approach in determining clinical staging and therapy of patients with non-Hodgkin's lymphoma, the authors carried out percutaneous liver biopsies in 33 untreated patients with this diseases. The liver biopsies were performed with Menghini's needle and the material was histologically and cytologically examined. Liver involvement was found in 9 (27%) patients. Based on the analyzed biopsies, the authors concluded that percutaneous liver biopsies represent a significant diagnostic approach in clinical staging and therapy of non-Hodgkin's lymphoma. The authors further compared the bioptical findings with physical examinations, biochemical blood tests and liver scintigraphy.
由于病理性肝脏病变的存在肯定会改变非霍奇金淋巴瘤患者临床分期和治疗的判定方法,作者对33例未经治疗的该疾病患者进行了经皮肝活检。肝活检采用Menghini针进行,对取材进行了组织学和细胞学检查。发现9例(27%)患者有肝脏受累。基于所分析的活检结果,作者得出结论,经皮肝活检是非霍奇金淋巴瘤临床分期和治疗的一种重要诊断方法。作者还将活检结果与体格检查、血液生化检查及肝脏闪烁扫描进行了比较。